The abstract is read at the publisher; the summary is JClub's.
In a substudy of 41 HBeAg-negative chronic hepatitis B patients, adjuvant PEG-IFNα after nucleos(t)ide analog withdrawal expands IL-10–producing regulatory B cells >5-fold while HBV-specific T cells contract.
- Why it matters: NUC withdrawal outcomes vary, and the immunologic mechanisms behind flares and sustained viral control are not fully defined.
- What they did: Using quality-controlled IFN-γ ELISpot with 15 genotype-matched HBV peptide pools plus multiparameter flow cytometry and intracellular IL-10 staining, the study tracked T-cell and B-reg kinetics before and during interventions.
- The result: Broader baseline IFN-γ–producing HBV-specific T cells correlated with sustained off-treatment viral control and fewer flares, while PEG-IFNα caused a transient T-cell reduction lasting >1 month; B-reg induction temporally tracked flares and inversely correlated with IFN-γ–producing T-cell frequencies.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.